TY - JOUR
T1 - Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study.
AU - Jones, DE
AU - Hollingsworth, KG
AU - Jakovljevic, DG
AU - Fattakhova, G
AU - Pairman, J
AU - Blamire, AM
AU - Trenell, MI
AU - Newton, JL
PY - 2012/2
Y1 - 2012/2
N2 - Background Chronic fatigue syndrome (CFS) patients frequently describe difficulties with repeat exercise. Here, we explore muscle bioenergetic function in response to three bouts of exercise.
Methods A total of 18 CFS (CDC 1994) patients and 12 sedentary controls underwent assessment of maximal voluntary contraction (MVC), repeat exercise with magnetic resonance spectroscopy and cardio‐respiratory fitness test to determine anaerobic threshold.
Results Chronic fatigue syndrome patients undertaking MVC fell into two distinct groups: 8 (45%) showed normal PCr depletion in response to exercise at 35% of MVC (PCr depletion >33%; lower 95% CI for controls); 10 CFS patients had low PCr depletion (generating abnormally low MVC values). The CFS whole group exhibited significantly reduced anaerobic threshold, heart rate, VO2, VO2 peak and peak work compared to controls. Resting muscle pH was similar in controls and both CFS patient groups. However, the CFS group achieving normal PCr depletion values showed increased intramuscular acidosis compared to controls after similar work after each of the three exercise periods with no apparent reduction in acidosis with repeat exercise of the type reported in normal subjects. This CFS group also exhibited significant prolongation (almost 4‐fold) of the time taken for pH to recover to baseline.
Conclusion When exercising to comparable levels to normal controls, CFS patients exhibit profound abnormality in bioenergetic function and response to it. Although exercise intervention is the logical treatment for patients showing acidosis, any trial must exclude subjects who do not initiate exercise as they will not benefit. This potentially explains previous mixed results in CFS exercise trials.
AB - Background Chronic fatigue syndrome (CFS) patients frequently describe difficulties with repeat exercise. Here, we explore muscle bioenergetic function in response to three bouts of exercise.
Methods A total of 18 CFS (CDC 1994) patients and 12 sedentary controls underwent assessment of maximal voluntary contraction (MVC), repeat exercise with magnetic resonance spectroscopy and cardio‐respiratory fitness test to determine anaerobic threshold.
Results Chronic fatigue syndrome patients undertaking MVC fell into two distinct groups: 8 (45%) showed normal PCr depletion in response to exercise at 35% of MVC (PCr depletion >33%; lower 95% CI for controls); 10 CFS patients had low PCr depletion (generating abnormally low MVC values). The CFS whole group exhibited significantly reduced anaerobic threshold, heart rate, VO2, VO2 peak and peak work compared to controls. Resting muscle pH was similar in controls and both CFS patient groups. However, the CFS group achieving normal PCr depletion values showed increased intramuscular acidosis compared to controls after similar work after each of the three exercise periods with no apparent reduction in acidosis with repeat exercise of the type reported in normal subjects. This CFS group also exhibited significant prolongation (almost 4‐fold) of the time taken for pH to recover to baseline.
Conclusion When exercising to comparable levels to normal controls, CFS patients exhibit profound abnormality in bioenergetic function and response to it. Although exercise intervention is the logical treatment for patients showing acidosis, any trial must exclude subjects who do not initiate exercise as they will not benefit. This potentially explains previous mixed results in CFS exercise trials.
KW - Chronic fatigue syndrome
KW - exercise
KW - fatigue
KW - muscle bioenergetics
KW - muscle function
UR - http://europepmc.org/abstract/med/21749371
UR - https://www.scopus.com/pages/publications/84855504732
U2 - 10.1111/j.1365-2362.2011.02567.x
DO - 10.1111/j.1365-2362.2011.02567.x
M3 - Article
C2 - 21749371
SN - 1365-2362
VL - 42
SP - 186
EP - 194
JO - European Journal of Clinical Investigation
JF - European Journal of Clinical Investigation
IS - 2
ER -